Evaluation of the intravenous immune globulin demonstration: the purpose of this requirement is to secure a qualified vendor to design and carry out an independent evaluation that informs the…
Ended Awarded Last action
- Contract number
- 75FCMC22F0007
- Awardee
-
Dobson Davanzo & Associates, LLC UEI KMGBTM89LNU3
- Awarding agency
-
Centers for Medicare and Medicaid Services
Department of Health and Human Services
- Obligated
- $1,836,326
Award facts
- Contract value 100% obligated
- $1,836,326.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Windsor Mill, Milford Mill, MD 21244, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,836,326 |
About this award
This is a firm-fixed-price delivery order awarded by the Centers for Medicare and Medicaid Services (CMS) to Dobson Davanzo & Associates, LLC, a woman-owned small business consulting firm. The purpose of the $1,836,326.00 contract is to design and carry out an independent evaluation that will inform the Intermediate and Final Report to Congress on the Intravenous Immune Globulin (IVIG) Access Demonstration. This evaluation and reporting effort is part of a larger IVIG program administered by CMS. The contract, which does not have a set-aside designation, was issued under Dobson Davanzo's existing Multiple Award Schedule (MAS) contract with the General Services Administration's Federal Acquisition Service. Dobson Davanzo is an experienced CMS contractor, having previously supported various Medicare and Medicaid initiatives through its expertise in healthcare policy, data analysis, and program evaluation.
Description
Evaluation of the intravenous immune globulin demonstration: the purpose of this requirement is to secure a qualified vendor to design and carry out an independent evaluation that informs the intermediate and final report to congress (RTC). This effo
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| National Opinion Research Center | $299,998 |
Quick answers
Who was awarded contract 75FCMC22F0007?
75FCMC22F0007 was awarded to Dobson Davanzo & Associates, LLC by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on December 22, 2021.
How much is contract 75FCMC22F0007 worth?
The government has obligated $1,836,326 on 75FCMC22F0007.
Is contract 75FCMC22F0007 an order under another contract?
Yes. 75FCMC22F0007 is a delivery order under 47QRAA21D002Y, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75FCMC22F0007 competed?
The extent of competition for 75FCMC22F0007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award